Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis. Avasarala J JAMA Neurol. 2014 Jun 9. PMID: 24911916. Abstract CommentRecommendBookmarkWatch